These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1692 related articles for article (PubMed ID: 18224663)

  • 61. The number of lymph node metastases influences survival and International Union Against Cancer tumor-node-metastasis classification for esophageal squamous cell carcinoma.
    Zhang HL; Chen LQ; Liu RL; Shi YT; He M; Meng XL; Bai SX; Ping YM
    Dis Esophagus; 2010 Jan; 23(1):53-8. PubMed ID: 19392846
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Incidence and prognostic significance of occult tumor cells in lymph nodes from patients with stage IIA colorectal carcinoma.
    Messerini L; Cianchi F; Cortesini C; Comin CE
    Hum Pathol; 2006 Oct; 37(10):1259-67. PubMed ID: 16949928
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The roles of neoadjuvant radiotherapy and lymphadenectomy in the treatment of esophageal adenocarcinoma.
    Solomon N; Zhuge Y; Cheung M; Franceschi D; Koniaris LG
    Ann Surg Oncol; 2010 Mar; 17(3):791-803. PubMed ID: 19953332
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [The patterns and prognostic factors of abdominal lymph node metastasis in patients with the middle thoracic esophageal squamous cell carcinoma].
    Wang Z; Liu XY; Liu FY
    Zhonghua Wai Ke Za Zhi; 2008 Dec; 46(23):1800-3. PubMed ID: 19094790
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Accurate lymph node assessment prior to trimodality therapy for esophageal carcinoma.
    Suntharalingam M; Haas ML; Sonett JR; Doyle LA; Hausner PF; Schuetz J; Greenwald B; Krasna MJ
    Cancer J; 2001; 7(6):509-15. PubMed ID: 11769864
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Risk factors that influence early death due to cancer recurrence after extended radical esophagectomy with three-field lymph node dissection.
    Kosugi S; Kanda T; Yajima K; Ishikawa T; Hatakeyama K
    Ann Surg Oncol; 2011 Oct; 18(10):2961-7. PubMed ID: 21499809
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Extent of lymph node removal during esophageal cancer surgery and survival.
    van der Schaaf M; Johar A; Wijnhoven B; Lagergren P; Lagergren J
    J Natl Cancer Inst; 2015 May; 107(5):. PubMed ID: 25748792
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Prediction of lymph node status in patients with superficial esophageal carcinoma: analysis of 160 surgically resected cancers.
    Shimada H; Nabeya Y; Matsubara H; Okazumi S; Shiratori T; Shimizu T; Aoki T; Shuto K; Akutsu Y; Ochiai T
    Am J Surg; 2006 Feb; 191(2):250-4. PubMed ID: 16442955
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Analysis of lymph node metastases of 217 cases of thoracic esophageal carcinoma and its impact on prognosis].
    An FS; Huang JQ; Chen SH
    Ai Zheng; 2003 Sep; 22(9):974-7. PubMed ID: 12969532
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Lymph node ratio: role in the staging of node-positive colon cancer.
    Wang J; Hassett JM; Dayton MT; Kulaylat MN
    Ann Surg Oncol; 2008 Jun; 15(6):1600-8. PubMed ID: 18327530
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Clinical study of modified Ivor-Lewis esophagectomy plus adjuvant radiotherapy for local control of stage IIA squamous cell carcinoma in the mid-thoracic esophagus.
    Chen G; Wang Z; Liu XY; Zhang MY; Liu FY
    Eur J Cardiothorac Surg; 2009 Jan; 35(1):1-7. PubMed ID: 18926712
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Predicting systemic disease in patients with esophageal cancer after esophagectomy: a multinational study on the significance of the number of involved lymph nodes.
    Peyre CG; Hagen JA; DeMeester SR; Van Lanschot JJ; Hölscher A; Law S; Ruol A; Ancona E; Griffin SM; Altorki NK; Rice TW; Wong J; Lerut T; DeMeester TR
    Ann Surg; 2008 Dec; 248(6):979-85. PubMed ID: 19092342
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Prognostic significance of perioperative blood transfusions in resectable thoracic esophageal cancer.
    Tachibana M; Tabara H; Kotoh T; Kinugasa S; Dhar DK; Hishikawa Y; Masunaga R; Kubota H; Nagasue N
    Am J Gastroenterol; 1999 Mar; 94(3):757-65. PubMed ID: 10086663
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A prospective trial for avoiding cervical lymph node dissection for thoracic esophageal cancers, based on intra-operative genetic diagnosis of micrometastasis in recurrent laryngeal nerve chain nodes.
    Miyata H; Yano M; Doki Y; Yasuda T; Yoshioka S; Sugita Y; Takiguchi S; Fujiwara Y; Monden M
    J Surg Oncol; 2006 May; 93(6):477-84. PubMed ID: 16615150
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Prognostic evaluation of patients with clinical T1 and T2 squamous cell carcinomas of the thoracic esophagus after 3-field lymph node dissection.
    Igaki H; Kato H; Tachimori Y; Nakanishi Y
    Surgery; 2003 Apr; 133(4):368-74. PubMed ID: 12717353
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Thoracic recurrent laryngeal lymph node metastases predict cervical node metastases and benefit from three-field dissection in selected patients with thoracic esophageal squamous cell carcinoma.
    Li H; Yang S; Zhang Y; Xiang J; Chen H
    J Surg Oncol; 2012 May; 105(6):548-52. PubMed ID: 22105736
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Ivor Lewis esophagectomy with two-field lymph node dissection for squamous cell carcinoma of the lower thoracic esophagus].
    Wu J; Chai Y; Zhou XM; Chen QX; Yan FL
    Ai Zheng; 2007 Mar; 26(3):307-11. PubMed ID: 17355797
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Adjuvant radiotherapy after modified Ivor-Lewis esophagectomy: can it prevent lymph node recurrence of the mid-thoracic esophageal carcinoma?
    Chen G; Wang Z; Liu XY; Liu FY
    Ann Thorac Surg; 2009 Jun; 87(6):1697-702. PubMed ID: 19463580
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Esophagectomy with extended lymphadenectomy for submucosal esophageal cancer: long-term outcomes and prognostic factors.
    Tanaka T; Matono S; Nagano T; Shirouzu K; Fujita H; Yamana H
    Ann Surg Oncol; 2012 Mar; 19(3):750-6. PubMed ID: 21861216
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer.
    Pawlik TM; Gleisner AL; Cameron JL; Winter JM; Assumpcao L; Lillemoe KD; Wolfgang C; Hruban RH; Schulick RD; Yeo CJ; Choti MA
    Surgery; 2007 May; 141(5):610-8. PubMed ID: 17462460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 85.